China Universal Asset Management Co., Ltd. Vir Biotechnology, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 29,202 shares of VIR stock, worth $301,072. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,202
Previous 26,280
11.12%
Holding current value
$301,072
Previous $196,000
9.18%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding VIR
# of Institutions
214Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$172 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$135 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$58 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$36.8 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.37B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...